Bison Capital Acquisition Corp. (BCAC) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2018

Xynomic Pharmaceuticals Holdings, Inc.

CIK: 1697805
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2018
Mar. 04, 2019
Jun. 30, 2018
Document and Entity Information [Abstract]   
Entity Registrant NameBison Capital Acquisition Corp.  
Entity Central Index Key0001697805  
Trading SymbolBCACU  
Amendment Flagfalse  
Current Fiscal Year End Date--12-31  
Document Type10-K  
Document Period End DateDec. 31, 2018  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2018  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Filer CategoryAccelerated Filer  
Entity Small Businesstrue  
Entity Shell Companytrue  
Entity Emerging Growth Companytrue  
Entity Ex Transition Periodfalse  
Entity Common Stock, Shares Outstanding 7,978,937 
Entity Public Float  $ 60,495,750

View differences made from one year to another to evaluate Xynomic Pharmaceuticals Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Xynomic Pharmaceuticals Holdings, Inc..


Assess how Xynomic Pharmaceuticals Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Xynomic Pharmaceuticals Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1697805
Form Type: 10-K Annual Report
Accession Number: 0001213900-19-003564
Submitted to the SEC: Tue Mar 05 2019 7:31:39 AM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: